Home › Funds › AMI ASSET MANAGEMENT CORP › NUVB

AMI ASSET MANAGEMENT CORP position in NUVB

NUVATION BIO INC · Health Care

AMI ASSET MANAGEMENT CORP reported holding 179,294 shares of NUVB (NUVATION BIO INC) in its Q3 2026 13F filing — a position valued at US$1.0M, representing 0.06% of its reported portfolio and ranking #48 among its reported holdings. AMI ASSET MANAGEMENT CORP has disclosed NUVB holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)179.29K sh
Reported value held$1.00M
Portfolio Weight0.06%
First reportedQ4 2025
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How AMI ASSET MANAGEMENT CORP's NUVB position evolved

AMI ASSET MANAGEMENT CORP first disclosed a stake in NUVB in Q4 2025 at 126,472 shares (US$1.1M). Across 4 filings, AMI ASSET MANAGEMENT CORP increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 179,294 shares valued at US$1.0M — a reduction of -3,957 shares quarter over quarter.. Notable position changes include a 52% increase in Q1 2026 (shares rose 32% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 126.47K $1.13M New
Q1 2026 192.43K $825.51K Add
Q2 2026 183.25K $1.04M Reduce
Q3 2026 179.29K $1.00M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About NUVB and 13F data

NUVB (NUVATION BIO INC) is a Health Care company. 55 other funds we track also report a position in NUVB — the largest reported positions include Decheng Capital LLC (US$147.4M), Context Capital Management, LLC (US$53.1M), Omega Fund Management, LLC (US$45.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding NUVB

All NUVB fund holders →

FAQ

How long has AMI ASSET MANAGEMENT CORP held NUVB?

AMI ASSET MANAGEMENT CORP has disclosed NUVB holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is AMI ASSET MANAGEMENT CORP's current position in NUVB?

As of Q3 2026, AMI ASSET MANAGEMENT CORP holds 179.29K shares of NUVB (NUVATION BIO INC), valued at $1.00M, representing 0.06% of its reported portfolio and ranking #48.

Has AMI ASSET MANAGEMENT CORP been buying or selling NUVB?

In the latest 13F filing (Q3 2026), AMI ASSET MANAGEMENT CORP reduced its position in NUVB.

Which other funds hold NUVB?

Other major institutional holders of NUVB include Decheng Capital LLC, Context Capital Management, LLC, Omega Fund Management, LLC, among 55 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.